Resnick Joshua 4
4 · KalVista Pharmaceuticals, Inc. · Filed Sep 29, 2017
Insider Transaction Report
Form 4
Resnick Joshua
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-09-27+6,000→ 6,000 totalExercise: $6.71Exp: 2027-09-26→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.
- [F2]The option is held by the reporting person for the benefit of SV Health Investors, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.